The fact that L-arginine does not induce diabetes could mean that L-arginine availability for NOS is compartmentalized at such degree that it could not reach appropriate concentrations to activate NOS (Km of eNOS for L-arginine ranges 1–10 μM) [5], thus limiting the use of this amino acid in the treatment of GDM. This evidence concerns the gene NOS3 and gestational diabetes.